Zydus, Torrent Pharma Partner to Co-Market Semaglutide Injection for Diabetes, Weight Management
Zydus, Torrent Pharma Partner to Co-Market Semaglutide Injection for Diabetes, Weight Management
- •Zydus Lifesciences and Torrent Pharmaceuticals have signed a licensing and supply agreement.
- •The partnership aims to co-market Semaglutide Injection in the Indian market for diabetes treatment.
- •Zydus will manufacture and supply the product, while Torrent Pharma will market it under its brand 'Sembolic'.
- •Torrent Pharma will pay an upfront licensing fee to Zydus for semi-exclusive rights.
- •Semaglutide Injection is indicated for type 2 diabetes mellitus and chronic weight management in adults.
